Junyi Ye

2.9k total citations
70 papers, 1.5k citations indexed

About

Junyi Ye is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Junyi Ye has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 32 papers in Cancer Research and 23 papers in Molecular Biology. Recurrent topics in Junyi Ye's work include Lung Cancer Treatments and Mutations (29 papers), Cancer Genomics and Diagnostics (26 papers) and Lung Cancer Research Studies (10 papers). Junyi Ye is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Cancer Genomics and Diagnostics (26 papers) and Lung Cancer Research Studies (10 papers). Junyi Ye collaborates with scholars based in China, United States and Russia. Junyi Ye's co-authors include Han Han‐Zhang, Yi‐Long Wu, Jin‐Ji Yang, Xu‐Chao Zhang, Hai‐Yan Tu, Zhen Wang, Daizhan Zhou, Xiaoling Weng, Lin He and Jie Huang and has published in prestigious journals such as Physical Review Letters, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Junyi Ye

68 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyi Ye China 22 728 607 563 423 133 70 1.5k
Wenjun Zhou China 19 818 1.1× 799 1.3× 927 1.6× 194 0.5× 102 0.8× 56 2.0k
Daniel T. Merrick United States 23 733 1.0× 703 1.2× 1.0k 1.8× 485 1.1× 106 0.8× 51 2.0k
Boram Lee South Korea 19 590 0.8× 456 0.8× 427 0.8× 346 0.8× 157 1.2× 88 1.3k
Shangli Cai China 21 548 0.8× 990 1.6× 615 1.1× 544 1.3× 158 1.2× 110 1.9k
Weijian Guo China 15 572 0.8× 589 1.0× 304 0.5× 170 0.4× 172 1.3× 72 1.4k
Paola Muzi Italy 23 467 0.6× 405 0.7× 661 1.2× 254 0.6× 67 0.5× 52 1.5k
Omar M. Rashid United States 25 415 0.6× 738 1.2× 786 1.4× 450 1.1× 78 0.6× 68 1.7k
Jay M. Lee United States 24 636 0.9× 914 1.5× 486 0.9× 249 0.6× 68 0.5× 89 2.0k
Jair Bar Israel 28 992 1.4× 1.5k 2.4× 832 1.5× 504 1.2× 146 1.1× 152 2.6k
E Kr̆epela Czechia 20 424 0.6× 710 1.2× 499 0.9× 384 0.9× 63 0.5× 46 1.5k

Countries citing papers authored by Junyi Ye

Since Specialization
Citations

This map shows the geographic impact of Junyi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi Ye more than expected).

Fields of papers citing papers by Junyi Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi Ye. The network helps show where Junyi Ye may publish in the future.

Co-authorship network of co-authors of Junyi Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Junyi Ye. A scholar is included among the top collaborators of Junyi Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyi Ye. Junyi Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Junyi, Xiaobin Zeng, Ao Lin, et al.. (2024). Robust positive association between serum urate and the risk of chronic obstructive pulmonary disease: hospital-based cohort and Mendelian randomisation study. BMJ Open Respiratory Research. 11(1). e002203–e002203. 5 indexed citations
2.
Zhang, Jianli, Junyi Ye, Shurong Wang, et al.. (2023). En Bloc Resection for Spinal Cord Hemangioblastomas: Surgical Technique and Clinical Outcomes. Journal of Neurological Surgery Part A Central European Neurosurgery. 85(6). 577–584. 2 indexed citations
3.
Liu, Zimin, Xiaoxiao Li, Ning Liu, et al.. (2021). HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 147(5). 1315–1324. 9 indexed citations
4.
Zhang, Dongzhi, Haiping Jiang, Junyi Ye, et al.. (2021). A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA. Journal of Cancer. 12(20). 6189–6197. 9 indexed citations
5.
Zhang, Bin, Lianmin Zhang, Dongsheng Yue, et al.. (2020). Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis. Translational Lung Cancer Research. 9(4). 1187–1201. 12 indexed citations
6.
Chen, Kaiyan, Fanrong Zhang, Junyi Ye, et al.. (2020). A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib. Clinical Lung Cancer. 22(1). e1–e4. 1 indexed citations
7.
Li, Guodong, Xin Zhao, Jianxing Xiang, et al.. (2020). High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy. Annals of Translational Medicine. 8(11). 685–685. 6 indexed citations
8.
Wang, Xinzhuang, Ming Gao, Junyi Ye, et al.. (2020). An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis. Frontiers in Genetics. 11. 612037–612037. 26 indexed citations
9.
Zheng, Mei-Mei, Yang-Si Li, Ben‐Yuan Jiang, et al.. (2019). Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC. Journal of Thoracic Oncology. 14(5). 924–932. 75 indexed citations
10.
Deng, Jiaying, Xiaoling Weng, Junyi Ye, et al.. (2019). Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing. Frontiers in Genetics. 10. 47–47. 12 indexed citations
11.
Yang, Dongyong, Yalun Li, Li Li, et al.. (2019). Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients. Cancer Biology and Medicine. 16(3). 556–564. 35 indexed citations
12.
13.
Li, Li, Yubo Wang, Lin Jiao, et al.. (2019). Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer. Cancer Letters. 452. 191–202. 54 indexed citations
14.
15.
Niu, Xiaomin, Fatao Liu, Yi Zhou, et al.. (2017). Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment. Clinical Cancer Research. 23(17). 5003–5014. 16 indexed citations
16.
Wang, Zhen, Jin‐Ji Yang, Jie Huang, et al.. (2017). Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance. Journal of Thoracic Oncology. 12(11). 1723–1727. 163 indexed citations
17.
Shao, Minhua, Bo Jin, Yanjie Niu, et al.. (2014). Association of POLK Polymorphisms with Platinum-Based Chemotherapy Response and Severe Toxicity in Non-small Cell Lung Cancer Patients. Cell Biochemistry and Biophysics. 70(2). 1227–1237. 19 indexed citations
18.
Xu, Jian, Junyi Ye, Yanting Wu, et al.. (2014). Reduced Fetal Telomere Length in Gestational Diabetes. PLoS ONE. 9(1). e86161–e86161. 58 indexed citations
19.
Weng, Xiaoling, Daizhan Zhou, Fatao Liu, et al.. (2014). DNA methylation profiling in the thalamus and hippocampus of postnatal malnourished mice, including effects related to long-term potentiation. BMC Neuroscience. 15(1). 31–31. 7 indexed citations
20.
Yang, Zhaoyang, Junyi Ye, Candong Li, et al.. (2013). Drug addiction is associated with leukocyte telomere length. Scientific Reports. 3(1). 1542–1542. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjun Zhou Breakdown of academic impact, for papers by Daniel T. Merrick Breakdown of academic impact, for papers by Boram Lee Breakdown of academic impact, for papers by Shangli Cai Breakdown of academic impact, for papers by Weijian Guo Breakdown of academic impact, for papers by Paola Muzi Breakdown of academic impact, for papers by Omar M. Rashid Breakdown of academic impact, for papers by Jay M. Lee Breakdown of academic impact, for papers by Jair Bar Breakdown of academic impact, for papers by E Kr̆epela
Rankless by CCL
2026